Keros Therapeutics Inc. (KROS)

KROS trades at $16.05, 7.0% above the near-term max pain of $15 expiring Oct 17, 2025 (19 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($10-$90), signaling increased put positioning or downside protection. Key magnetic zone at 13 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for KROS shows a downward trend from 90 to 10, indicating bearish sentiment or hedging activity. The 310% spread signals divergent expectations across timeframes. Most levels below 16.05 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.